Thursday, November 29, 2012

Snippet: ToI Reports Sutent/Sunitinib Matter Remanded to the Patent Office by Supreme Court

The Times of India has today reported that the Supreme Court has remanded the Sutent patent matter to the Patent Office for a hearing, and also set aside the injunction on Cipla's Sunitinib. This means the revocation of the Sutent patent of Sugen Inc has been set aside. The effect of this on proceedings for alleged infringement remains to be seen.

No comments:

Post a Comment